The July 2026 advisory review could reopen compounding pathways for peptides previously curtailed in 2023 over immunogenicity ...
At AMCP 2026, Daryl Pritchard, PhD, highlighted fragmentation, evidence gaps, and decision support needs limiting precision ...
Kelsea Aragon, PharmD, highlights the role of long-acting HIV therapies like lenacapavir and cabotegravir in improving ...
The end of 2025 saw the expiration of the enhanced premium subsidies under the Affordable Care Act (ACA) after Congress was ...
The authors updated a diagnosis list to identify low-acuity emergency department visits by veterans and applied it to examine ...
Rising Specialty Drug Costs and Co-Pay Models Raise Access Concerns: Patty Taddei-Allen, PharmD, MBA
In addition to the models, Taddei-Allen also pointed out the overall shift in employer plan drug costs, shifting more of the ...
Results released April 1, 2026, by the American Society for Radiation Oncology (ASTRO), which represents more than 10,000 ...
Steven Kheloussi, PharmD, explains how care coordination and transparent policies can improve MS treatment adherence, ...
Managed care organizations must move beyond early, low-risk artificial intelligence (AI) use to strategically governed, ...
EHR validation in 406,230 “relaxed” and 127,151 “strict” patients showed stable PREVENT discrimination across sexes, ...
A breast cancer diagnosis doesn't land only on the patient, but rather it ripples through an entire household. In this ...
Adam Colburn, JD, highlights 3 federal bills to expand value-based care, digital therapeutics, and pharmacist reimbursement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results